SMARCB1 and schwannoma: This finding, and the incomplete penetrance of disease seen in LZTR1‐associated schwannomatosis, suggests that germline LZTR1 variants may carry a lower risk of symptomatic schwannoma disease than other genes, such as SMARCB1 and NF2.